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ABSTRACT
Total healthcare expenditures and expenditures as a percentage of GDP have been
substantially higher in the U.S. than in Canada between 1975 – 2008. Hospitalcare,
physician and clinical services, and drug prescription expenditures have been the
principal components contributing to growth in healthcare expenditures in the U.S.
compared to Canada. This study reviews the literature on increasing healthcare costs
and establishes some comparative and descriptive analysis for high healthcare costs in
the two countries during this time period. The study also analyses and compares the
growth of healthcare costs.
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Introduction
A healthy population is believed to be a driver and a catalyst for achieving
economic growth. The health of any nation is of paramount importance and has a
positive correlation with economic growth Sachs et al. (2001). Health means the state of
being fit and mentally balanced to react to changes in the environment. Generally
speaking, it is a state of wellness and completeness of a person. Alleyne et al. (2002)
revealed that health consistently ranked the number one thing men and women desired
in life.
Variations in healthcare expenditures among countries are substantial regardless
of how they are measured. Across the globe, many countries have continuously
increased healthcare budgets. Leslie Norwalk, former acting administrator for Center
for Medicare & Medicaid Services (CMS) in a press release by CNNMoney in 2011 stated
that “healthcare spending will double by 2020, and the government will pay 50% of that
-- this is troubling”. Auerbach an economist at RAND Corporation in a press release in
2011 argues that “unless we reverse the trend, Americans increasingly will notice that
health costs compromise their other spending options.
Research has also shown that a healthy population is a necessary requirement for
economic growth. This trend was shown in the work of Fogel (1991, 1997, 2000), whose
ground - breaking studies have explained the relationship between body size and food
supply, and have shown the latter to be critical to long – term labor productivity.
Szick et al. (1999) of the Institute for Clinical and Evaluative Sciences Ontario Canada
have found that four decades ago, Canada and U.S. operated similar healthcare systems,
but the situation has changed drastically since 1984 when Canada passed the Canadian
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full single payer system (Canadian Health Act of 1984) revising the Medical Care Act of
1966 which prohibits user fees and extra fees from doctors. They stated that several
studies have compared healthcare cost and outcomes. However, none of these studies
provided conclusive evidence why there is a difference between U.S. and Canada
healthcare system.
The relationship between health and economic growth has also been established
by studies on a more modest scale considering groups of children who can be separated
according to the calorie intakes during their first 3 years of life. It is clear from these
studies that those with higher calorie intakes generally attain higher incomes 30 years
later in life, and are therefore presumably more economically productive (Hernandez,
Fuentes, and Pascual, 2001).
These results could be the rationale behind spending on health. Healthy countries
with educated men and women have the potential to grow economically, especially in a
favorable policy environment. Clements et al. (2012) of the International Monetary
Fund (IMF) and Ginsburg (2006) indicates that healthcare costs have increased in
developing and developed countries for more than two decades, and this is causing
serious debates and reevaluation of the benefits and performance of healthcare
spending.
According to the Henry J. Kaiser Family Foundation (2009) healthcare costs
around the world are steadily growing faster than general economic growth and a
majority of countries have seen healthcare spending as a percentage of their gross
domestic product (GDP) increase over time. The Organization for Economic Co-operation
and Development (OECD) health data (2006) shows that healthcare spending is
increasing at a higher rate than incomes in developing and developed countries. This has
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raised serious questions about how countries will pay for their future healthcare needs.
Growth in healthcare expenditures has been particularly high in the U.S. The OECD
health data (2006) show that the U.S. spends much more per capita on healthcare and
also has the largest spending growth rates in the world. The percentage of wealth the U.S.
spends on healthcare services is fast becoming worrisome to economists, its citizens and
health practitioners in the U.S., far surpassing other developed countries like Canada.
This paper further stated that a major challenge is that U.S. does not have better
healthcare records in terms of life expectancy, number of physicians per capita and
number of nurses per 1,000 population when compared to other developed countries like
Canada despite huge expenditure in healthcare services.
Over the years, the healthcare systems of U.S. and Canada have been studied and
compared by several analysts with further work ongoing. The most difficult question left
unanswered is whether the expected healthcare outcomes of patients in these two
countries would be the same if identical techniques and methods are applied in both
countries in treatment of patients. Szick, et al. (1999) stressed that little research has
been directed at this question. This study seeks to improve our understanding of the
differences in healthcare expenditure growth in the U.S. and Canada. The study covers
the period between 1975 through 2008.
Literature Review
The literature review is organized in two sections. First, I reviewed the literature
focusing on the connection between economic growth and health in general. Secondly, I
report on findings in the literature specific to the growth of healthcare expenditures the
U.S. and Canada.
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Health and Economic Growth
The connection between health and economic growth has long been established
in the literature, for instance Bloom et al. (2005) stated that health is an important form
of human capital and it can enhance workers’ productivity by increasing their physical
capacities, such as strength and endurance. The importance of health and investment in
healthcare are major components of the development goals pursued by developing and
developed countries around the globe. The increasing attention healthcare delivery is
receiving worldwide has further emphasized the importance of health and healthcare
expenditure on economic growth.
Higher expenditure on health alone cannot meet a given nation’s development
goals. However, in conjunction with other social investments, it can drive economic
growth. A healthy person is full of life and energy and a healthy society tends to be
energetic and actively involved in productive ventures. The work of Baldacci (2004)
elucidates the importance of health expenditures. His panel data analysis based on
about one hundred and twenty developing countries from 1975-2000 indicated that
spending on health affects growth within that same period, while lagged health
expenditures appear to have no noticeable effect on growth.
Spending in healthcare services can lead to improvements in health. There are
several studies showing that improvements in health can positively influence economic
growth through its effects on fertility, labor productivity, and the quality of human
capital. For example, Sachs (2001) and Bloom et al. (2005) find positive correlations
between health and economic growth.
However, there are some disagreements and divergent views concerning the
effects of increased healthcare spending. For instance, Baldacci et al. (2003) and Gupta
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et al. (2002b) find that social spending is an important determinant of education and
health outcomes. This work, based on cross-sectional data for developing countries,
reveals that expenditures on education have a greater effect on social indicators than
health expenditures.
Despite these differences, most studies find a positive relationship between
health and economic growth. Levine and Renelt (1992) and Sala-I-Martin (1997a,
1997b) find that out of more than 32,000 regressions involving permutations of over 60
variables, initial life expectancy is a positive and significant predictor of economic
growth in more than 96 percent of the specifications. This indicates that good health at
early age and beyond is one of the most robust predictors of subsequent economic
growth and could justify the increased levels of spending in healthcare by developing
countries like India and Nigeria and developed countries like U.S. and Canada.
This is corroborated by Sachs (2001), who finds that “extending the coverage of
crucial health services to the world’s poor could save millions of lives each year, reduce
poverty, spur economic development, and promote global security. According to this
view, achieving better healthcare may be able to accomplish what development
practitioners, NGOs, economists, foreign aid providers, and diplomacy have failed to
achieve. Several researchers who have found a significant correlation from health to
growth (e.g., Bloom and Canning, 2003) have used these types of findings to argue for
large increases in governmental spending on health care.
Health and education have also been found to be influential factors in human
capital formation. Advanced levels of education attainment create an enabling
environment for awareness among the public and the ability of families to solve their
health problems. For example, Barro (1996b) argues that improved health can reduce
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the depreciation of education capital, and thus increase the favorable effect of education
on growth. A more recent study by Gyimah- Brempong and Wilson (2004) finds a
positive and robust link between investment in health and growth in both sub-Saharan
African and OECD countries.
Growth in Healthcare Spending
Empirical studies suggest the existence of a correlation between the growth of an
economy and growth in governmental social and economic spending. For example,
Devarajan, et al., (1996) show that moderated and prudent expenditure can lead to
development but could be unproductive if it becomes excessive especially in developing
countries. The Milken Institute report (2007), suggests that as a country’s health
improves (as calculated by several factors, such as improvement in Medicare and health
research) we should expect to see an improvement in labor productivity and output per
worker, as well as an increase in economic growth.
Improvement in health may lead to income growth, but this does not necessarily
imply that developing and developed nations should allocate a greater percentage of
their budget on healthcare. As Bloom and Canning (2003: 313,) state, “The key issue is
not that spending on health would be good, it is whether spending on health is better
than other uses of the limited funds available in developing countries.”
As a nation grows in size and population, it is expected that other traditional functions
of the state would rise in importance, and there would be a natural force exerting
pressure on public expenditure thereby increasing the cost of governance and
administration of a state and country in social and economic activities. For instance,
expenditures on education and infrastructural development could reduce as a result of
increased expenditure in healthcare services. For example, Cincotta and Engelman
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(1997) emphasized that decline in fertility (population reduction more or less fueled
economic growth during the early 1990s in countries like Taiwan, South Korea,
Thailand, Hong Kong, Malaysia and Indonesia.
Developed and developing nations have over the years shifted attention to
investments in health-related activities because of its social benefits in both in the short
run and long run. OECD health data (2006) has shown that this universal tendency of
increased spending on healthcare has become a trend among nations of the world. The
questions that need urgent answers are (1) for how long will this trend continue? (2) Are
the social benefits derived from these actions commensurate with the expenditures? and
(3) what are the best ways of measuring the costs and benefits of such a trend?
Roehrig et al. (2012) find that control in healthcare expenditure started about 2.5 years
before the recession engulfed the economy in 2008, therefore the economy cannot be
held accountable for the slowdown in the curve. He further stated that economists and
policy makers often compare the growth of health care spending to that of the overall
economy, as measured by the gross domestic product (GDP), but this comparison can
give a false sense of “excess” healthcare spending growth during economic recessions
and recoveries. Woolhandler (2003) finds that the difference between U.S. and
Canadian expenditure on healthcare administration has grown steadily over the years,
and that large sums could be saved in the U.S. if healthcare administration costs are cut
by adopting the Canada’s single payer healthcare system. Redelmeier (1993) finds that
after all adjustments are made for population size and the exchange rate between the
U.S. and Canada, the reasons for the high healthcare expenditure in the U.S. is
attributable to higher administrative costs, hospital costs, physician services, and
prescription drugs.
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Szick et al. (1999) find that U.S. and Canada operated the same healthcare
systems about four decades ago before Canada restructured its system in the 1984.
According to the Kaiser family foundation (2009) the portion of GDP earmarked for
healthcare spending in the U.S. grew from 9% of GDP in 1980 to 16% of GDP in 2008.
This percentage increase in health spending as a portion of GDP is high when compared
with other developing and developed countries. Also, OECD health data (2004) shows
that the U.S. spent US$6,714 per-capita on health care expenses, while Canada spent
US$3,678. In the same year, the U.S. spent 15.3% of GDP on healthcare while Canada
spent 10.0%.
OECD health data (2004) and Mckinsey Global Institute (2008) report shows
that U.S. healthcare expenditure as a proportion of GDP has been unstable over the
years compared to Canada’s. Schabloski (2008) finds that the main difference between
the U.S. and Canadian healthcare systems is that while the U.S. effectively runs a private
managed healthcare system, Canada adopts a comprehensive, publicly funded
healthcare system. The U.S. is the only country in the developed world, and one of only
two OECD countries, that does not already have a fundamentally public- tax-supported
healthcare system.
The report on healthcare by Canada Institute for Health Information (CIHI) 2010
and the Commonwealth Fund (2011) reveal that Canada’s healthcare system provides
universal coverage for hospital services, physicians and prescription drugs for its
citizens and permanent residents. The Canadian healthcare regulation ensures that all
insured persons be fully insured, without co-payments and other associated medical
fees. The trademark of Canada’s universal healthcare system includes the nonexistence
of copayments and the government directly provides and funds a wide range of
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preventive services through Public Health Agency of Canada. The Canadian system is
often advocated as an alternative that the U.S. might emulate. The U.S. health system
requires that some of its citizens’ pay for their healthcare needs, and the Kaiser
Commission on Medicaid and the Uninsured (2006) finds that about 15%, or 40 million
American residents, were reported to be uninsured at any point in time in 2004.
Another difference between the two systems is in their administration. The report
on the state of the healthcare in Canada (2002) by Canada health act revealed that in
Canada, the government is wholly committed to provide funds and public health
services to its district governments for healthcare expenditures, provided they accept
the Canadian healthcare regulations, which clearly and explicitly disallow billing
patients’ treatments that are covered by Medicare. The authors also find that Canadian
hospitals are managed by private boards/and or regional health authorities that are
separated from the government.
In the U.S., the federal government funds Medicare, Medicaid, and state health
insurance for children. Those types of people covered include qualified old citizens, the
poor, persons with disabilities, and children. The Kaiser Commission on Medicaid and
the Uninsured (2006) find that a majority of residents in the U.S. have access to
healthcare through their employers, while the unemployed or individuals whose
employers do not have coverage pay from their pockets. However, federal and state
agencies are actively involved in healthcare spending irrespective of private
involvement. The U.S. Department of Health and Human Services, Centers for Disease
Control and Prevention (2010), found that federal and state agencies pay about 47% of
the $2.2 trillion spent nationally on medical care in 2004.
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Schabloski (2008) and International Profiles of Healthcare Systems (2010) find
that Canadian system has been 60–74% publicly funded, but these services are
administered by private providers. Canada’s healthcare system does not cover certain
services. Comparing the merits of private versus public healthcare funding, one is
tempted to conclude that privately funded healthcare is not attractive. OECD data (2011)
shows that the U.S. has the most expensive healthcare system in the world. A study by
Harvard Medical School researchers Steffie Woolhandler and David Himmelstin in July
2006 and OECD health data 2011, reveal that irrespective of the outstanding technology
that the U.S. possesses; the overall health of the U.S. population is actually worse than
in most developed countries, and the mortality rates are relatively high in the U.S.
However, these ‘aggregate’ measures are not necessarily accurate, as many other
reasons outside healthcare affect mortality.
The U.S. has continued with the same healthcare system decades after Canada
restructured its system. This difference in healthcare in the U.S. and Canadian systems
reveals that private funding may lead to poorer public health. Squires (2012) stated that
in all industrialized countries, U.S. is the only country without universal insurancebased or tax financed systems. Rodin and Ferranti (2012) also revealed that among 25
wealthiest Nations, only the U.S. does not have some form of universal coverage. They
further stated that several middle-income countries, including Brazil, Mexico, and
Thailand have universal healthcare system while Lower-income nations, such as the
Philippines, Vietnam, India, China, South Africa, Rwanda, and Ghana are working
towards adopting universal healthcare system. Kelly (2009) projects that the U.S. would
be able to save over $160 billion every year in administration expenses if it adopts the
Canadian system of healthcare.
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Docteur et al. (2009) finds that death rates are high in the U.S. compared to
OECD countries. Devereaux et al. (2004) finds that the high death rates have been
linked to unprofessional and unethical practices of for-profit hospitals that need to
maximize profit for stakeholders and compensate hospital managers. They find that
hospital administrators tend to employ less-skilled practitioners to lessen costs. This
study therefore suggests that many patients will die if profit motives are the reasons for
establishing hospitals.
The switch by Canada to a universal system is believed by some to be the main
reason why Canadians are generally healthier regardless of income when compared to
U.S. residents. Also, Squires (2012) finds that one potential explanation for the high
level of U.S. health care spending is the aging population. As the baby boom generation
enters retirement age there is correspondingly greater healthcare needs. In addition, an
analysis by Anderson (2011) shows that U.S. prices for drugs, brand-name drugs, and
procedures are highest in the 30 most-commonly prescribed drug categories compared
to Canada.
Comparative Analysis

As shown in Figures 1 and 2, using the data collected from CIHI and NHEA the
gap between the spending on healthcare in total and as a portion of GDP in the U.S. and
Canada has grown steadily since 1975. The Canada Institute for Health Information
CIHI (2012) report shows that the pace of growth is slowing however. The three major
components of total healthcare expenditure in the U.S. and Canada are hospitalcare,
physician and clinical services, and prescription drugs. However, public health, other
professional services, other health institutions and other health spending make up the
other categories of healthcare expenditure that are less significant compared to the three
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major components. The CIHI (2012) report indicates that drug spending growth rates
have trended downward over the last 10 years in Canada. This decline is likely due to
fewer drugs coming on the market in the last decade, many blockbuster drugs patent,
and CIHI (2010) data shows that in 2008 the total healthcare expenditure in the U.S. is
$2,339 billion and in Canada it is $172 billion while Figure 2 shows that the proportion
of the U.S. healthcare expenditure as percentage of

GDP in the same year was 17.8%

while in Canada it was 10.7%.
Figures 3 and 4 show changes in different healthcare expenditure components
per unit of GDP in the U.S. and Canada from 1975 - 2008. According to the Henry J.
Kaiser Family Foundation (2010), the U.S spent $234.1 billion in 2008 on prescription
drugs, which is about six times the amount ($40.3) billion spent in
From Figure 3 and 4, we see that the three different healthcare expenditure
components in Canada and the U.S. have followed almost the same pattern since 1975,
with only slight variations. This is validated by CIHI (2012) report which shows that
reimbursement paid to health care providers has been one of the major cost drivers of
hospital and physician spending in Canada. The report further stated that increases in
compensation due to higher demand as well as to growth in the number of hospital
workers and physicians may have added to higher spending during the last decade. In
Canada, the drug prescription expenditure per GDP was 0.60% in 1975 and 1980.
However, by 2007 it has risen to 1.7%.
Figures 5, 6 and 7 compare the hospitalcare, physician services, and drug
prescription services expenditure per GDP in the U.S. and Canada. From Figure 5, we see
that the hospitalcare spending per GDP in 1975 and 1980 was higher in the U.S. than in
Canada. It was 3.2% and 3.6% in 1975 and 1980 respectively in the U.S., while in Canada
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it is 2.9% in 1975 and 1980. However, the gap was high in 2008; it is 5.5% in the U.S.
while it is 3.1% in Canada. From Figure 6, we see that the physician services expenditure
per GDP was also higher in the U.S. compared to Canada. It was 0.6% in Canada in 1975
and 1.5% in the U.S. and in 2008 it was 3.8% in the U.S. while in Canada it is 1.4%. From
Figure 7, the drug prescription expenditure per GDP has been higher in Canada
compared to the U.S. since 1975. It was 0.6% in 1975, 1.0% in 1990 and 1.4% in 2000 in
Canada while in the U.S. it was 0.5% 1975, 0.7% in 1990 and 1.2% in 2000. However,
between 2008 and 2012 the drug prescription expenditure in the U.S. was higher
compared to Canada after several years. It was 1.8% in 2008 in the U.S. and 1.7% in
Canada. According to the Henry J. Kaiser Family Foundation (2010), the rate of increase
in spending on drug prescription since year 2000 with the exception of year 2006 in the
U.S. was as a result of increased use of prescription drugs which was due to a number of
factors including the implementation of Medicare Part D, increased use of specialty
drugs, lower refunds from drug manufacturers and changes in the mix of drugs (both
brand versus generic). Medicare Part D is also called the Medicare prescription drug
benefit, a federal program to subsidize the costs of prescription drugs for Medicare
beneficiaries in the United States. According to CIHI (2012) report and Jonathan (2005),
the steady decrease in drug prescription expenditure in Canada are as a result of
government strict regulations on drug utilizations and price controls that limit the
increase in prescription drug prices while in the U.S. the steady increase in drug
prescription expenditure could be attributed to the non-existent of enforced government
regulations on drug and controls to limit the increase in prescription drug prices.
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Model Specification
The model used is a simple ordinary least squares semi-log approach to estimate
growth rates for spending on hospital care, physician and clinical services, and
prescription drugs in both the U.S. and Canada (Gujarati and Porter, 2010).This
approach was chosen because it gives better approximation in calculating growth rate, it
gives closer connection between the process of linear growth and exponential growth.
The advantages of semi-log specification include; easy interpretation of coefficients and
it mitigates the impact of nonlinear relationships.
Let Yt represent health care spending in year t, Y0 represents the value of
healthcare spending in time 0 and r is the rate of growth of Y over time. Starting with
the simple growth formula
Yt  Y0 1  r 

t

……………………… (1)

Transforming the model by taking the natural log of (1), we have

ln Yt  ln Y0  t ln(1  r ) …….…… (2)
Now, letting lnY0  B1 and ln(1  r )  B2 , we use the simple regression model

ln Yt  B1  B2t   t …………….. (3)
Also let
=
ln

vary whether or not there was a recession the previous year.
+

=

+

Recession
+

Recession
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Growth Rate Estimates
To estimate the growth rate in healthcare spending, we transform (1). The estimates of
the growth rate (r) can be derived from ln(1  r )  B2 .Transforming the expression by
exponentiation we have
r=

– 1 ……………………….. (4)

The essence of estimating it using the data collected is to compare the results with the
analysis in literature review and see if they are in agreement.
Roehrig et al. (2012) suggests that healthcare spending may vary across the
business cycle. We therefore allow B2 to vary according to whether or not there was a
recession in year t. To allow for the possibility of lagged effects, we also estimate
specifications where B2 is allowed to vary according to whether or not there was a
recession the previous year. The reason for varying B2 is to ascertain if recession has
effect on healthcare spending or not.
Results
Our regression results are reported in Tables 1 and 2. The growth rates implied by
these estimates are reported in Tables 3 and 4. We find that the average growth rate for
total spending on healthcare services in the United States is 8.70%. For Canada, our
estimate is 7.70% etc. The main reason for estimating the growth rate using the data
collected from CIHI and NHEA is to compare the results of studies in the literature
review. The growth rate estimate in table 3 and 4 were gotten using equation 4.
The findings from this study and analysis in the literature review definitely
revealed that U.S. spends more than Canada on healthcare services. The growth rate is

16

higher in the overall total healthcare in the U.S. compared to Canada. Also, the growth
rate is higher in the U.S. compared to Canada in hospitalcare services, physician and
clinical services and prescription drug. The graphs showed that the growth rate in
healthcare expenditure in both countries is positive each year between 1975 and 2008.
The regression analyses only show that the growth rate is not statistically different during
or after recession year in either country. The results revealed that recession or economic
crisis might have contributed less to the fall in healthcare cost. Nevertheless, the
healthcare costs are extremely high in both countries.
Summary
Healthcare Costs have been both high and growing steadily in the U.S. and
Canada during the years 1975 to 2008. The findings from our studies of healthcare costs
in the U.S. and Canada provide a convincing answer to the question of how the United
States compares to Canada in terms of the spending in healthcare. This is simply
because the growth rate estimate of spending in total healthcare, hospital care,
physician and clinical services and drug prescription in the U.S. is higher compared to
Canada.
There is a big gap between the U.S. and Canadian spending on healthcare. Huge
sum of money could be saved by the U.S. if cost of administration, abuse, fraud and
prescription drugs is reduced by implementing similar or modified system as found in
Canada.
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Conclusions
Changes in government policy, fraud and abuse, medical technology, aging
population, increased usage of prescription drugs, spending in hospitalcare services,
physician and clinical services, administrative cost and population growth are some of
the reasons why healthcare cost have risen so high in U.S. and Canada. Growing
healthcare costs have created worries that continued growth could negatively affect the
economy of U.S. and Canada, as well could create problems for overall spending in the
economy such as expenditure in education and infrastructural developments. The
literature review as shown by the work of Baldacci (2004) and Bloom and Canning
(2003) emphasized the connection between the growth of healthcare cost and rate of
economic development.
I found that recession and absence of recession does not have a statistical
significant effect on healthcare spending. This study attempts to compare U.S. and
Canada health expenditures. Progresses in medicine make people to spend more on
healthcare in order to prolong life. Modifications in government policy and other
endogenous variables increase health expenditures. This study has provided the
descriptive analysis of how modifications in government programs such as Medicare
and Medicaid could account for increased spending on health in the U.S. compared to
Canada.
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Figure 2: Total Healthcare Expenditure Per GDP
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Figure 3: U.S. Healthcare Expenditure Components Per GDP
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Figure 4: Canada Healthcare Expenditure Components Per GDP
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Figure 5: Hospitalcare Expenditure Per GDP
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Figure 6: Physician & Clinical Services Expenditure Per GDP
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Figure 7: Prescription Drug Expenditure Per GDP
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Figure 8: Other Expenditure Per GDP
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Table 1: United States
VARIABLES
Year
…*Recession

Total Spending
0.0841***

Hospital Spending

0.0842***

0.0840***

0.0740***

(41.00)

(39.59)

(41.371)

--

-0.0007

--

0.0740***

0.0739***

0.0889***

(32.38)

(31.19)

(32.70)

--

-0.000

--

(-0.26)
…*Recession
Last Year

--

--

0.0040

--

--

Observations
R-squared

…*Recession

Observations
R-squared

0.1098***

0.1096***

(32.25)

(31.17)

(32.25)

--

-0.0011

--

(98.40)

(96.01)

(99.53)

--

-0.0012

----

(-0.30)
0.0046

--

--

(-0.83)
0.0044

--

--

0.0023

(1.02)

(1.32)

5.068***

5.058***

4.190***

4.190***

4.179***

3.405***

3.406***

3.395***

1.880***

1.881***

1.875***

(123.17)

(121.33)

(122.02)

(91.41)

(89.93)

(90.58)

(61.58)

(60.68)

(60.39)

(84.18)

(83.77)

(83.49)

34

34

34

34

34

34

34

34

34

34

34

34

0.981

0.981

0.982

0.970

0.970

0.972

0.970

0.970

0.971

0.997

0.997

0.997

Table 2: Canada
Hospital Spending

Total Spending

Physician and Clinical Spending

Prescription Drug Spending

0.0743***

0.0742***

0.0743***

0.0591***

0.0588***

0.0590***

0.0729***

0.0726***

0.0728***

0.1002***

0.1004***

0.1002***

(29.41)

(28.31)

(29.79)

(19.24)

(18.50)

(19.32)

(17.86)

(17.16)

(17.89)

(42.68)

(41.23)

(43.27)

--

0.0011

--

--

0.0016

--

--

0.0013

--

--

-0.0009

--

(0.40)

--

--

0.0053

2.7196***

2.7191***

(53.63)

(52.84)

(0.26)

--

--

0.0055

2.7068***

1.9572***

1.9565***

(53.19)

(31.78)

(31.34)

(1.37)
Constant

0.1096***

(1.30)

(0.33)
…*Recession
Last Year

0.0888***

5.067***

VARIABLES
Year

Prescription Drug Spending

0.0891***

(-0.010)

(1.27)
Constant

Physician and Clinical Spending

(-0.29)

--

--

0.0070

1.9439***

0.7734***

0.7728***

(31.20)

(9.44)

(9.29)

(1.16)

--

--

0.0050

0.7566***

0.1297***

0.1301**

0.1176**

(9.11)

(2.75)

(2.72)

(2.49)

(1.10)

(1.39)

34

34

34

34

34

34

34

34

34

34

34

34

0.964

0.964

0.966

0.920

0.921

0.924

0.909

0.909

0.912

0.983

0.983

0.984
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United States
Canada

Table 3: Growth Rate Estimates
Physician and
Total Spending
Hospital Spending
Clinical Services
8.784
7.680
9.318
7.702
6.056
7.530

Prescription
Drug Spending
11.605
10.561

